Page last updated: 2024-09-04

16-methylcyprenorphine and Coronary Disease

16-methylcyprenorphine has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kane, K; McIntosh, M; Parratt, J2

Other Studies

2 other study(ies) available for 16-methylcyprenorphine and Coronary Disease

ArticleYear
Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia.
    European journal of pharmacology, 1992, Jan-07, Volume: 210, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Electrophysiology; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Hemodynamics; Male; Morphinans; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

1992
The electrophysiological effects of opioid receptor-selective antagonists on sheep Purkinje fibres.
    European journal of pharmacology, 1992, Jan-07, Volume: 210, Issue:1

    Topics: Acidosis; Action Potentials; Animals; Coronary Disease; Hyperkalemia; Hypoxia; Morphinans; Naltrexone; Narcotic Antagonists; Purkinje Fibers; Sheep

1992